• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Neurometrix

NeuroMetrix slides on Q4 losses

January 28, 2021 By Sean Whooley

NeuroMetrix (NSDQ:NURO) shares dipped today on fourth-quarter results that showcased losses despite an improved bottom line. The Woburn, Mass.-based company posted losses of -$325,767 on sales of $1.8 million for the three months ended Dec. 31, 2020, for a 69.2% bottom-line gain on sales growth of 6%. NeuroMetrix experienced headwinds from the COVID-19 pandemic and felt […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Pain Management, Patient Monitoring, Wall Street Beat Tagged With: coronavirus, COVID-19, Neurometrix

NeuroMetrix launches Quell app for Apple Watch

September 23, 2020 By Sean Whooley

NeuroMetrix (NSDQ:NURO) announced that it launched the Quell Watch App for transcutaneous electrical nerve stimulation (TENS). Woburn, Mass.-based NeuroMetrix’s Quell app, which is now available for download from the Apple App Store, allows users of the Quell system to personalize and manage their therapy discreetly on iPhone and Android smartphones, according to a news release. Quell […]

Filed Under: Business/Financial News, Health Technology, Neuromodulation/Neurostimulation, Pain Management, Patient Monitoring, Software / IT Tagged With: Neurometrix

FTC to refund Neurometrix consumers $3.9M in false ad case

September 9, 2020 By Sean Whooley

The Federal Trade Commission announced that it is refunding NeuroMetrix (NSDQ:NURO) consumers nearly $3.9 million after false advertising. NeuroMetrix marketed its Quell transcutaneous electrical nerve stimulation device as a clinically proven and FDA-cleared treatment for widespread chronic pain relief when placed below the knee, according to the FTC, which said that the company lacks scientific evidence […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management Tagged With: Federal Trade Commission (FTC), Neurometrix

MedTech 100 roundup: Industry remains on the rise

July 27, 2020 By Sean Whooley

The medtech industry continues to climb back up in the markets, following a landmark week with another move up toward its pre-COVID-19-pandemic highs. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.29 points at the end of last week (July 24). That total represents just a […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: Align Technology, becton dickinson, coronavirus, COVID-19, Edwards Lifesciences, Haemonetics, Intuitive Surgical, MedTech 100 Index, Neurometrix, Pfizer, Philips, The Medtronic Foundation, Thermo Fisher Scientific

NeuroMetrix improves bottom line despite nearly halved Q2 sales

July 23, 2020 By Sean Whooley

NeuroMetrix (NSDQ:NURO) shares dipped today after posting second-quarter results that reflected the effects of the COVID-19 pandemic. The Woburn, Mass.-based pain-treating transcutaneous electrical nerve stimulation (TENS) device developer posted losses of -$851,944 on sales of $$1.4 million for the three months ended June 30, 2020, for a 74.7% bottom-line gain on a sales decline of 42.2%. […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Neurometrix

MedTech 100 roundup: Medtech stocks hit highest point since early March

April 27, 2020 By Sean Whooley

Medtech stocks generally ended last week at their highest point in more than a month — even as the COVID-19 pandemic continues to cause economic havoc. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.3 points at the end of last week (April 24). That […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Abbott, Baxter, coronavirus, COVID-19, Dow Jones, MedTech 100 Index, Medtronic, Neurometrix, Philips, S&P

NeuroMetrix dips on Q1 losses

April 23, 2020 By Sean Whooley

NeuroMetrix (NSDQ:NURO) shares fell today on first-quarter losses that reflected the impact of COVID-19 on its business. The Woburn, Mass.-based pain-treating transcutaneous electrical nerve stimulation (TENS) device developer posted losses of -$657,371 on sales of $2.2 million for the three months ended March 31, 2020, seeing its bottom line slide into the red from profits of […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Neurometrix

NeuroMetrix settles $4m false advertising case with FTC

March 4, 2020 By Nancy Crotti

Pain-treating TENS device company NeuroMetrix (NSDQ:NURO) has agreed to pay at least $4 million to settle a false advertising case brought by the Federal Trade Commission FTC. The commission said today that the Woburn, Mass.-based company also agreed to stop making deceptive claims that its Quell device treats pain throughout the body when placed below the […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management Tagged With: Federal Trade Commission (FTC), Neurometrix

NeuroMetrix CEO cuts his salary to $1

December 31, 2019 By Chris Newmarker

Dr. Shai N. Gozani, CEO of pain-treating TENS device company NeuroMetrix (NSDQ:NURO), is cutting his annual salary to $1 from a previous $422,200 — accepting a stock option to purchase 100,000 shares instead. The 2020 executive compensation package, approved Dec. 29 by the company board’s compensation committee, also cuts salaries in return for stock options for […]

Filed Under: Business/Financial News, Digital Health, Featured, Neuromodulation/Neurostimulation, Pain Management Tagged With: Neurometrix

How NeuroMetrix seeks to better relieve pain with AI

March 1, 2019 By Nancy Crotti

NeuroMetrix plans to add artificial intelligence to the latest iteration of its Quell transcutaneous electrical nerve stimulation (TENS) device. AI will allow Quell 2.0 to tailor treatment to each individual user, according to the Waltham, Mass.–based based company. Launched in September 2018 Quell 2.0 is 50% smaller and 20% more powerful than the original Quell, […]

Filed Under: Big Data, Digital Health, Featured, Health Information Technology, News Well, Pain Management, Software / IT Tagged With: AI, artificial intelligence, Neurometrix, opioid crisis

NeuroMetrix lands $4m milestone payment from GSK deal

August 23, 2018 By Sarah Faulkner

NeuroMetrix (NSDQ:NURO) said this week that it reeled in a $3.8 million milestone payment from its collaboration with GlaxoSmithKline‘s (NYSE:GSK) consumer healthcare unit. The strategic deal between the two groups was first announced in January this year. According to the terms of the deal, GSK acquired exclusive ownership of NeuroMetrix’s Quell pain-relief device outside the U.S., in exchange for […]

Filed Under: Funding Roundup, Pain Management, Wall Street Beat Tagged With: GlaxoSmithKline plc, Neurometrix

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 9
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS